eli lilly glp 1 market share and Novo Nordisk are dominating the GLP-1 drug world — but why is demand skyrocketing?💊🚀 Swipe left to find out ⬅️ #GLP1 #WeightLossDrugs # EliLilly #NovoNordisk #Ozempic #Mounjaro #ObesityCrisis #HealthcareTrends #INDmoney # Eli Lilly's Oral GLP‑1 Win

On the other hand, semaglutide and tirzepatide produce dramatically more weight loss than Pendulum

If you want maximum weight loss Retatrutide is the current frontrunner for maximum weight loss in clinical trials

Better glucose and lipid dynamics Even in people without diabetes, GLP-1 medications can improve post-meal metabolic spikes

That could shift

Originally developed for type 2 diabetes, it has shown exceptional results in clinical trials for weight loss

With a projected net effect of around $18 billion in additional Medicare spending over a decade, our model shows that GLP-1 drugs still dont pay for themselves yet at the new price, Kim said